| Product Code: ETC7539056 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India cancer gene therapy market import shipment demonstrated a declining trend over the period 2020-2024, indicated by a negative CAGR of -1.7%. The market experienced a significant contraction in growth between 2023 and 2024, with a decline of -25.5%. This reflects a notable slowdown in market expansion, suggesting a challenging landscape for import shipments in the sector.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Cancer Gene Therapy Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Cancer Gene Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 India Cancer Gene Therapy Market - Industry Life Cycle |
3.4 India Cancer Gene Therapy Market - Porter's Five Forces |
3.5 India Cancer Gene Therapy Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.6 India Cancer Gene Therapy Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Cancer Gene Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in India |
4.2.2 Growing investments in research and development of gene therapy technologies |
4.2.3 Favorable government initiatives and policies supporting cancer treatment and gene therapy |
4.3 Market Restraints |
4.3.1 High cost associated with gene therapy treatments |
4.3.2 Limited awareness and acceptance of gene therapy among patients and healthcare professionals |
5 India Cancer Gene Therapy Market Trends |
6 India Cancer Gene Therapy Market, By Types |
6.1 India Cancer Gene Therapy Market, By Therapy |
6.1.1 Overview and Analysis |
6.1.2 India Cancer Gene Therapy Market Revenues & Volume, By Therapy, 2021- 2031F |
6.1.3 India Cancer Gene Therapy Market Revenues & Volume, By Gene Induced Immunotherapy, 2021- 2031F |
6.1.4 India Cancer Gene Therapy Market Revenues & Volume, By Oncolytic Virotherapy, 2021- 2031F |
6.1.5 India Cancer Gene Therapy Market Revenues & Volume, By Gene Transfer, 2021- 2031F |
6.2 India Cancer Gene Therapy Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 India Cancer Gene Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 India Cancer Gene Therapy Market Revenues & Volume, By Diagnostic centers, 2021- 2031F |
6.2.4 India Cancer Gene Therapy Market Revenues & Volume, By Research Institutes, 2021- 2031F |
7 India Cancer Gene Therapy Market Import-Export Trade Statistics |
7.1 India Cancer Gene Therapy Market Export to Major Countries |
7.2 India Cancer Gene Therapy Market Imports from Major Countries |
8 India Cancer Gene Therapy Market Key Performance Indicators |
8.1 Number of clinical trials and research studies related to gene therapy in India |
8.2 Adoption rate of gene therapy treatments in cancer patients |
8.3 Number of gene therapy products approved for cancer treatment in India |
9 India Cancer Gene Therapy Market - Opportunity Assessment |
9.1 India Cancer Gene Therapy Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.2 India Cancer Gene Therapy Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Cancer Gene Therapy Market - Competitive Landscape |
10.1 India Cancer Gene Therapy Market Revenue Share, By Companies, 2024 |
10.2 India Cancer Gene Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here